After being ruled out for the remainder of the 2024-25 season, Victor Wembanyama earned some positive news about his Spurs future.
Budding superstar San Antonio Spurs center Victor Wembanyama has just been ruled out for the rest of the 2024-25 NBA season with an ominous new injury that could have major implications for his basketball future.
ESPN insider Shams Charania reported that Spurs center Victor Wembanyama will miss the rest of the season with deep vein thrombosis in his shoulder.
Victor Wembanyama’s promising second NBA season has been cut short due to an injury, per reports. ESPN NBA Insider Shams Charania reported on Thursday that the San Antonio Spurs star will miss the remainder of the 2024-2025 season with a deep vein thrombosis in his right shoulder.
The San Antonio Spurs were met with some very unfortunate news on Thursday afternoon as according to ESPN's Shams Charania, center Victor Wembanyama is expected to miss the remainder of the 2024-25 season with a deep vein thrombosis in his right shoulder.
Devastating news was announced Thursday morning from ESPN's Shams Charania that All-Star San Antonio Spurs center Victor Wembanyama is out for the season after finding deep vein thrombosis in his shoulder.
The official diagnosis for Wembanyama's injury is deep vein thrombosis in his right shoulder, which is the same ailment Bosh dealt with towards the end of his career. According to ESPN's Shams Charania,
The San Antonio Spurs shocked the NBA world on Thursday when they revealed that star center Victor Wembanyama had suffered a season-ending injury. Shortly after the news came to light, NBA insider Shams Charania shared a concerning revelation about Wembanyama's injury.
ESPN insider Shams Charania reported that Spurs center Victor Wembanyama will miss the rest of the season with deep vein thrombosis in his shoulder.
Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.
After suffering a mild stroke back in November, Gregg Popovich's future with the Spurs has become uncertain in 2025 and beyond.